COOPS Med has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2k. Its solvency ranks better than 5% of 2297 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
No current score
Insufficient figures
A score requires measurable solvency, liquidity and profitability. Missing figures are not a judgement about the company.
Axes
Profitability-
Solvency25
Growth-
Track record67
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
0.2%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 2297 sector peers (2025).
NBB · sector comparisonPosition among 2297 sector peers
Solvency
better than 5%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
2 d early
← before the deadline
after the deadline →
Financials · fiscal year 2025, abbreviated schema
Equity
€2k
Total assets
€1.36M
Net result
Not included in this filing
Working capital
€-64k
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Balance-sheet composition
Assets €1.36M
Fixed assets
€67k
Current assets
€1.30M
Equity and liabilities €1.36M
Equity
€2k
Debt
€1.36M
Debt finances 99.8% of the balance-sheet total.
Key figures and ratios
EBITDA
€10k
Solvency
0.2%
Current ratio
0.95
Quick ratio
0.95
Interest coverage
22.15
Debt
€1.36M
Debt ≤ 1 year
€1.36M
Income taxes
€220
Staff costs
€366k
A ratio outside any meaningful range has been withheld (balance sheet total €1.36M, equity €2k).
Filed annual accounts
As filed with the NBB · 2025
Balance sheet
Code2025
Assets
Total assets20/58€1.36M
Fixed assets21/28€67k
Tangible fixed assets22/27€67k
Plant, machinery and equipment23€26k
Other tangible fixed assets26€41k
Current assets29/58€1.30M
Amounts receivable within one year40/41€547k
Trade receivables40€547k
Cash at bank and in hand54/58€740k
Deferred charges and accrued income490/1€9k
Equity and liabilities
Total equity and liabilities10/49€1.36M
Equity10/15€2k
Contributions10/11€2k
Amounts payable17/49€1.36M
Amounts payable within one year42/48€1.36M
Trade debts44€1.32M
Suppliers440/4€1.32M
Taxes, remuneration and social security45€37k
Taxes450/3€6k
Remuneration and social security454/9€31k
Accrued charges and deferred income492/3€1k
Income statement
Code2025
Remuneration, social security and pensions62€366k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10k
Other operating charges640/8€3k
Gross operating margin9900€379k
Operating profit (loss)9901€569
Financial income75/76B€108
Recurring financial income75€108
Financial charges65/66B€456
Recurring financial charges65€456
Profit (loss) for the period before taxes9903€220
Income taxes67/77€220
Social balance
Average headcount (FTE)90874.9
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
29-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
NBB filing
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2024
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Lange Leemstraat 9a2018 AntwerpenGround area
205 m²
Building footprint
205 m²
Volume, LiDAR
3,664 m³
Parcel 11810K2740/00B003, Flanders · tallest building 21.3 m, ±6 floors. Linked by address, not a title deed.
1 establishment unit
COOPS Med
since 20242.368.674.276
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11810K2740/00B003 | Flanders | 205 m² | 1 · 205 m² | 21.3 m · 6 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
CAGA
BE 0789.827.151
Genk · Eq €2k
Docteur Sandrine CAO S.R.L.
BE 0743.846.082
Neupré · Eq €2k
ELKE VAN OOST GYNAECOLOGIE
BE 0761.473.952
Sint-Pieters-Leeuw · Eq €2k
DR. A. STURTEWAGEN, URGENTIEGENEESKUNDE-ANESTHESIE
BE 0764.508.864
Deinze · Eq €2k
Stratospire
BE 0769.578.994
Schaarbeek · Eq €2k
Of 16,617 companies in sector 86220 we hold annual accounts for 7,970. 969 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded13-12-2024
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 1 filingAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.